tag:www.gov.uk,2005:/search/news-and-communications News and communications 2025-06-09T14:04:20+01:00 HM 바카라 사이트 tag:www.gov.uk,2005:/government/news/chikungunya-vaccine-ixchiq-temporarily-paused-in-people-aged-65-and-over-as-precautionary-measure 2025-06-09T14:04:20+01:00 Chikungunya vaccine (IXCHIQ) temporarily paused in people aged 65 and over as precautionary measure This is a precautionary measure while the MHRA conducts the safety review. tag:www.gov.uk,2005:/government/news/women-on-skinny-jabs-must-use-effective-contraception-mhra-urges-in-latest-guidance 2025-06-05T00:01:03+01:00 Women on 바카라 사이트skinny jabs바카라 사이트 must use effective contraception, MHRA urges in latest guidance  Anyone who suspects that they바카라 사이트ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA.  tag:www.gov.uk,2005:/government/news/mhra-approves-aumolertinib-to-treat-non-small-cell-lung-cancer 2025-06-03T00:00:00+01:00 MHRA approves aumolertinib to treat non-small cell lung cancer As with all products, we will keep its safety under close review tag:www.gov.uk,2005:/government/news/mhra-approves-polihexanide-to-treat-acanthamoeba-keratitis 2025-05-23T00:00:00+01:00 MHRA approves polihexanide to treat acanthamoeba keratitis As with any medicine, the MHRA will keep the safety and effectiveness of polihexanide under close review.바카라 사이트 tag:www.gov.uk,2005:/government/news/mhra-approves-vaccine-to-protect-against-pneumococcal-infections-such-as-pneumonia-and-meningitis 2025-05-15T17:11:51+01:00 MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/mhra-approves-first-uk-treatment-for-congenital-thrombotic-thrombocytopenic-purpura-cttp 2025-05-12T17:41:15+01:00 MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP)  As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/mhra-approves-teprotumumab-as-the-first-uk-treatment-for-adults-with-moderate-to-severe-thyroid-eye-disease-ted 2025-05-07T00:00:00+01:00 MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED) As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/vimkunya-vaccine-approved-to-prevent-disease-caused-by-the-chikungunya-virus-in-people-12-years-of-age-and-older 2025-05-01T16:51:31+01:00 Vimkunya vaccine approved to prevent disease caused by the chikungunya virus in people 12 years of age and older  The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to prevent disease caused by the chikungunya virus in people 12 years of age and older.  tag:www.gov.uk,2005:/government/news/mhra-authorises-cancer-treatment-variation-with-an-administration-time-of-3-5-minutes 2025-04-30T15:17:40+01:00 MHRA authorises cancer treatment variation with an administration time of 3바카라 사이트5 minutes As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/acoramidis-approved-to-treat-wild-type-or-variant-transthyretin-amyloidosis-in-adults-with-cardiomyopathy 2025-04-25T11:54:57+01:00 Acoramidis approved to treat wild-type or variant transthyretin amyloidosis in adults with cardiomyopathy As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/obecabtagene-autoleucel-conditionally-approved-to-treat-adults-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukaemia 2025-04-25T00:00:00+01:00 Obecabtagene autoleucel conditionally approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/mhra-approves-first-uk-treatment-for-friedreichs-ataxia-omaveloxolone 2025-04-23T16:26:45+01:00 MHRA approves first UK treatment for Friedreich바카라 사이트s ataxia, omaveloxolone As with all products, we will keep its safety under close review. tag:www.gov.uk,2005:/government/news/marstacimab-approved-to-treat-patients-aged-12-years-and-above-weighing-at-least-35-kg-with-haemophilia-a-or-b 2025-04-22T11:09:20+01:00 Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/professor-claire-stewart-appointed-to-the-commission-on-human-medicines-as-three-members-reappointed 2025-04-17T14:12:39+01:00 Professor Claire Stewart appointed to the Commission on Human Medicines as three members reappointed The appointment will involve a time commitment of 22 days per year. Remuneration for the role will be at a rate of £325 per attendance and preparation for meetings. tag:www.gov.uk,2005:/government/news/trastuzumab-deruxtecan-approved-to-treat-adults-with-her2-positive-cancer-that-has-spread-or-cannot-be-removed-by-surgery 2025-04-09T00:00:00+01:00 Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that has spread or cannot be removed by surgery  As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/eplontersen-approved-to-treat-adults-with-rare-inherited-nerve-disease-or-polyneuropathy 2025-04-04T11:34:24+01:00 Eplontersen approved to treat adults with rare inherited nerve disease or polyneuropathy The Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), which is a rare progressive 바카라 사이트 tag:www.gov.uk,2005:/government/news/world-first-as-mhra-approves-trofolastat-for-diagnostic-imaging-of-prostate-cancer-in-men 2025-03-28T10:04:12+00:00 World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men  As with all products, the MHRA will keep its safety under close review. tag:www.gov.uk,2005:/government/news/new-study-shows-mhra-collaboration-with-hospital-dna-sequencing-service-cuts-time-to-diagnose-infections 2025-03-07T17:07:02+00:00 New study shows MHRA collaboration with hospital DNA sequencing service cuts time to diagnose infections In a UK-first, the Medicines and Healthcare products Regulatory Agency (MHRA) and Barts Health NHS Trust have developed a DNA sequencing approach that can be implemented onsite in hospitals so they can diagnose bacterial inf바카라 사이트 tag:www.gov.uk,2005:/government/news/triple-combination-medicine-deutivacaftortezacaftorvanzacaftor-approved-for-cystic-fibrosis 2025-03-07T00:00:00+00:00 Triple combination medicine deutivacaftor/tezacaftor/vanzacaftor approved for cystic fibrosis As with all products, the MHRA will keep its safety under close review tag:www.gov.uk,2005:/government/news/lazertinib-approved-for-use-in-combination-with-amivantamab-for-the-treatment-of-adults-with-non-small-cell-lung-cancer 2025-03-06T00:00:00+00:00 Lazertinib approved for use in combination with amivantamab for the treatment of adults with non-small cell lung cancer  As with all products, the MHRA will keep its safety under close review.